CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)		Ordinary Shares [Member] Class B Ordinary Shares [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Mar. 02, 2021		$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Mar. 02, 2021		0
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of Class B ordinary shares to Sponsor	[1]	$ 863	24,137	0	25,000
Issuance of Class B ordinary shares to Sponsor (in shares)	[1]	8,625,000
Net income (loss)		$ 0	0	(8,530)	(8,530)
Ending balance at Mar. 31, 2021		$ 863	24,137	(8,530)	16,470
Ending balance (in shares) at Mar. 31, 2021		8,625,000
Beginning balance at Mar. 02, 2021		$ 0	0	0	0
Beginning balance (in shares) at Mar. 02, 2021		0
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net income (loss)					(11,043)
Ending balance at Jun. 30, 2021		$ 863	24,137	(11,043)	13,957
Ending balance (in shares) at Jun. 30, 2021		8,625,000
Beginning balance at Mar. 31, 2021		$ 863	24,137	(8,530)	16,470
Beginning balance (in shares) at Mar. 31, 2021		8,625,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net income (loss)		$ 0	0	(2,513)	(2,513)
Ending balance at Jun. 30, 2021		$ 863	24,137	(11,043)	13,957
Ending balance (in shares) at Jun. 30, 2021		8,625,000
Beginning balance at Dec. 31, 2021		$ 863	0	(23,889,167)	(23,888,304)
Beginning balance (in shares) at Dec. 31, 2021		8,625,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Current period accretion of Class A ordinary shares to redemption value			0	(59,056)	(59,056)
Net income (loss)		$ 0	0	5,657,484	5,657,484
Ending balance at Mar. 31, 2022		$ 863	0	(18,290,739)	(18,289,876)
Ending balance (in shares) at Mar. 31, 2022		8,625,000
Beginning balance at Dec. 31, 2021		$ 863	0	(23,889,167)	(23,888,304)
Beginning balance (in shares) at Dec. 31, 2021		8,625,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net income (loss)					6,875,640
Ending balance at Jun. 30, 2022		$ 863	0	(17,458,797)	(17,457,934)
Ending balance (in shares) at Jun. 30, 2022		8,625,000
Beginning balance at Mar. 31, 2022		$ 863	0	(18,290,739)	(18,289,876)
Beginning balance (in shares) at Mar. 31, 2022		8,625,000
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Current period accretion of Class A ordinary shares to redemption value			0	(386,214)	(386,214)
Net income (loss)		$ 0	0	1,218,156	1,218,156
Ending balance at Jun. 30, 2022		$ 863	$ 0	$ (17,458,797)	$ (17,457,934)
Ending balance (in shares) at Jun. 30, 2022		8,625,000

[1] Share amounts for the periods ended include an aggregate of up to 1,125,000 shares of Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7).